85 related articles for article (PubMed ID: 12218879)
21. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Soyka M; Apelt SM; Lieb M; Wittchen HU
J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
[TBL] [Abstract][Full Text] [Related]
22. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
23. [The financial impact of maintenance treatment in heroin addictive behavior: the case of Subutex].
Kopp P; Rumeau-Pichon C; Le Pen C
Rev Epidemiol Sante Publique; 2000 Jun; 48(3):256-70. PubMed ID: 10891786
[TBL] [Abstract][Full Text] [Related]
24. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
[TBL] [Abstract][Full Text] [Related]
25. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
26. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
27. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function.
Shmygalev S; Damm M; Weckbecker K; Berghaus G; Petzke F; Sabatowski R
Drug Alcohol Depend; 2011 Sep; 117(2-3):190-7. PubMed ID: 21353749
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of buprenorphine maintenance therapy programs in the Ukraine: first promising treatment outcomes.
Schaub M; Subata E; Chtenguelov V; Weiler G; Uchtenhagen A
Eur Addict Res; 2009; 15(3):157-62. PubMed ID: 19420948
[TBL] [Abstract][Full Text] [Related]
29. Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial.
Bell JR; Ryan A; Mutch C; Batey R; Rea F
Drug Alcohol Depend; 2008 Jul; 96(1-2):183-6. PubMed ID: 18423901
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
31. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
Mintzer MZ; Correia CJ; Strain EC
Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664
[TBL] [Abstract][Full Text] [Related]
32. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
[TBL] [Abstract][Full Text] [Related]
33. [Changes in psychosocial symptoms of opiate users over six months with buprenorphine/naloxone substitution therapy].
Petke Z; Csorba J; Meszaros J; Vingender I; Farkas J; Demetrovics Z; Kovacs Z; Menczel Z; Pataki Z; Simor P; Havasi A; Melles K; Marvanykovi F; Racz J
Neuropsychopharmacol Hung; 2012 Mar; 14(1):7-17. PubMed ID: 22427466
[TBL] [Abstract][Full Text] [Related]
34. [High-dose buprenorphine prescription in southern France from 1999 to 2001].
Mancini J; Thirion X; Masut A; Ronflé E; Coudert C; Pradel V; Frauger E; Micallef J
Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S7-14. PubMed ID: 12910029
[TBL] [Abstract][Full Text] [Related]
35. Heroin detoxification with a single high dose of buprenorphine.
Kutz I; Reznik V
Isr J Psychiatry Relat Sci; 2002; 39(2):113-9. PubMed ID: 12227226
[TBL] [Abstract][Full Text] [Related]
36. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
[TBL] [Abstract][Full Text] [Related]
37. Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling.
Kornør H; Waal H; Ali RL
Drug Alcohol Rev; 2006 Mar; 25(2):123-30. PubMed ID: 16627301
[TBL] [Abstract][Full Text] [Related]
38. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management.
Roux P; Villes V; Blanche J; Bry D; Spire B; Feroni I; Carrieri MP
Drug Alcohol Depend; 2008 Sep; 97(1-2):105-13. PubMed ID: 18479840
[TBL] [Abstract][Full Text] [Related]
39. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
Lavie E; Fatséas M; Denis C; Auriacombe M
Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.
Levy S; Vaughan BL; Angulo M; Knight JR
J Adolesc Health; 2007 May; 40(5):477-82. PubMed ID: 17448411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
